Ardsley Advisory Partners

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Ardsley Advisory Partners
CRD #160595
SEC #801-73664
CIK #0000900529
AUM
Employees 13 (54% Investors, 0% Brokers)
Fees
Minimum
Phone203-564-4200
Address262 Harbor Drive
Stamford, CT 06902
Source [IAPD] [EDGAR] [Website]
Total AUM ($M)
1300104078052026002001200920172025
Fees and Compensation — Form ADV Part 2A (1/23/2019) [Brochure]
ITEM 5 – FEES AND COMPENSATION
The Ardsley Funds offer private investment fund interests/shares only to certain qualified investors and
admission to the Ardsley Funds is not open to the general public. Private investment fund interests/shares
are sold only to qualified investors who are “Accredited Investors” under Rule 501 of Regulation D of the
Securities Act of 1933, as amended, and “Qualified Eligible Persons” under Regulation 4.7 of the
Commodity Exchange Act. Given the Ardsley Funds’ ownership restrictions, Ardsley has determined to
limit the sale of private investment fund interests/shares to “Qualified Purchasers”; as such term is defined
in Section 2(a) (51) of the Investment Company Act of 1940, as amended.

Please refer to the applicable Fund’s PPMs for a complete description of that Fund’s fee schedule.

Ardsley deducts fees from each Fund’s assets at the beginning of each fiscal quarter. In the case of a partial
fiscal quarter; the Management Fee is calculated on a pro rata basis, based on the applicable percentage for
the partial quarter and is repaid to the Fund and distributed to the investor. To the extent a capital
contribution or withdrawal is made as of any day that is not the first day of a fiscal quarter, the Management
Fee is prorated.

Ardsley also charges performance based compensation in the form of an incentive allocation (the “Incentive
Allocation”) for all Funds except the Advanced Healthcare Fund/Ridgecrest Fund. The Incentive
Allocation is generally calculated each month and paid as of the last day of each fiscal year. Under the loss
carryforward provision, generally an Investor will not be charged an Incentive Allocation until any net loss
previously allocated to such Investor has been offset by subsequent net profits.

Ardsley or the General Partner, in their respective sole discretion, may, in effect, waive, reduce or rebate
the Management Fee or the Incentive Allocation for certain Investors. It should be noted that Ardsley
employees and personnel do not pay an Incentive Allocation in connection with their investments in the
Funds. Further, the Management Fee for all internal capital (i.e., an investment from an Ardsley employee
and personnel) in the Funds is typically 0.50% (annualized). The Management Fee for all other Investors
in the Ardsley Funds (except Ridgecrest Fund, which is not subject to a Management Fee) is typically
0.25% (annualized).

The Funds’ PPMs set forth the fees and expenses to be paid by Investors. Prospective Investors should
carefully review the PPMs and a Fund’s governing documents prior to investing in a Fund.

Ardsley will bear all expenses incurred in connection with the offer and sale of interests in the Flagship
Fund, Renewable Energy Fund, and the Healthcare Fund.

The Ardsley Funds will also bear all legal, accounting expenses, administrative and all other operating
expenses.

The Funds bear all investment expenses, including interest expenses, brokerage commissions, custodial
fees, taxes, expenses related to the purchase and sale of illiquid securities, and any other expenses which
the General Partner reasonably determines should not be considered Administrative Expenses of the
applicable Fund.

It should also be noted that to the extent a trade error occurs, Fund losses caused by trade errors due to gross
negligence, bad faith or willful misconduct on the part of Ardsley or its employees will be reversed with
Ardsley being responsible to make the affected Funds whole. However, pursuant to Ardsley’s offering
documents, the applicable Funds are required to bear the costs of any other trading errors.

Investors in the Flagship Fund, may generally make withdrawals from their capital account in the Flagship
Fund as follows: (i) at the end of any fiscal quarter, upon 45 days’ prior written notice, an Investor may
withdraw up to 25% of its capital account; and (ii) at the end of any fiscal year, upon 30 days’ prior written
notice, an Investor may withdraw any amount from their capital account.

Investors in the Renewable Energy Fund can exercise 100% liquidity upon 30 days’ notice at the end of
any quarter. Ardsley or the General Partner may require or permit the withdrawal of an Investor under such
other circumstances as they, in their sole discretion, deem appropriate for any of the Funds.

It is critical that Investors refer to their respective Fund’s offering documents for a complete
understanding of how fees are calculated and deducted from their assets. The information contained
herein is a summary only and is qualified in its entirety by the relevant Fund’s offering documents.
Account Minimums and Types of Clients — Form ADV Part 2A (1/23/2019) [Brochure]
ITEM 7 – TYPES OF CLIENTS
As described in Item 4, Ardsley offers investment advisory services to pooled investment vehicles operating
as private investment funds.

As described in Item 5.A, above, each Investor must meet certain suitability requirements. In addition, the
minimum initial investment for the Ardsley Funds is $1,000,000, and the minimum additional contribution
is $100,000. The minimum initial investment for the Renewable Energy Fund is $1,000,000, and the
minimum additional contribution is $250,000.

As stated in Item 4.A, the Employee Funds solely accept investments from Ardsley employees and
personnel and the Advanced Healthcare Fund is open only to Ardsley employees, personnel, and Philip
Hempleman’s family members.
Sector Form 13F Holdings Value ($M)
Sandisk Corp 56.7
Advanced Micro Devices Inc 54.0
Sezzle Inc 36.9
Ikonics Corp 23.7
BrightSpring Health Services Inc 22.7
eBay Inc 22.3
Sunrun Inc 21.4
JDS Uniphase Corp /CA/ 18.6
ARM Holdings PLC /UK 16.6
Shoals Technologies Group Inc 16.5
View All
Holdings by Sector ($M)
1300104078052026002011201620212027
Type Form D Funds Date Sold AUM
HF Ardsley Ridgecrest Partners Fund LP [2014-03-28] 30.3 M 26.3 M
Filed 2024-11-18 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Ardsley Offshore Fund Ltd [2012-02-14] 4.8 M 15.2 M
Filed 2012-03-12 (D/A) · Exemption 506, 3(c)(1) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Ardsley Partners Institutional Fund LP 2012-02-14 198.0 M
HF Ardsley Renewable Energy Offshore Fund Ltd [2012-02-14] 5.0 M 4.7 M
Filed 2012-03-12 (D/A) · Exemption 506, 3(c)(1) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 7 895.3
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 7 895.3
By Discretionary
Discretionary 7 895.3
Non-Discretionary 0 0.0
Total 7 895.3
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 895.3
Total 7 895.3
Form D Directors Role # Filings # Firms 2011 - 2026
Neil Glass Director 20 9
Philip Hempleman Executive Officer 8 3
Ardsley Advisory Partners LP Promoter 8 3
Spencer Hempleman Executive Officer 8 3
Ardsley Partners I GP LLC Executive Officer 8 3
Ardsley Partners I Executive Officer 3 3
Willy Weber Director 3 2
Ardsley Advisory Partners Promoter 3 2
Steven Napoli Director 2 1
EDGAR Form CIK 2011 - 2026
13F-HR [0000900529]
3 [0000900529]
4 [0000900529]
SC 13D [0000900529]
SC 13G [0000900529]
Form 13D/13G Filer Form 13D/13G Subject Filed
Ardsley Advisory Partners LP Aspire Biopharma Holdings Inc [2026-02-12]
Ardsley Advisory Partners LP Bioceres Crop Solutions Corp [2023-01-25]
Ardsley Advisory Partners LP Stronghold Digital Mining Inc [2022-02-08]
Ardsley Advisory Partners LP Marrone Bio Innovations Inc [2022-02-08]
Ardsley Advisory Partners LP Cantaloupe Inc [2022-02-08]
Ardsley Advisory Partners LP USA Technologies Inc [2020-02-07]
Ardsley Advisory Partners LP Just Energy Group Inc [2020-02-07]
Ardsley Advisory Partners LP Sunopta Inc [2019-02-12]
Ardsley Advisory Partners Marrone Bio Innovations Inc [2018-02-07]
Ardsley Advisory Partners American Superconductor Corp /DE/ [2017-05-08]
Ardsley Advisory Partners Marrone Bio Innovations Inc [2017-05-05]
Ardsley Advisory Partners Bluerock Residential Growth REIT Inc [2015-04-16]
Ardsley Advisory Partners Applied Optoelectronics Inc [2015-02-20]
Ardsley Advisory Partners BioScrip Inc [2015-02-09]
Ardsley Advisory Partners Independence Realty Trust Inc [2014-12-10]
Ardsley Advisory Partners World Energy Solutions Inc [2014-01-10]
Ardsley Advisory Partners Supernus Pharmaceuticals Inc [2013-12-12]
Ardsley Advisory Partners Canadian Solar Inc [2013-08-19]
Ardsley Advisory Partners Hannon Armstrong Sustainable Infrastructure Capital Inc [2013-05-28]
Ardsley Advisory Partners Hi-Crush Partners LP [2012-12-27]
Ardsley Advisory Partners Saba Software Inc [2012-12-14]
Ardsley Advisory Partners Active Power Inc [2012-03-16]
Firm Profile (Form ADV)
Discretionary AUM$0.7B
ServesInstitutional
Fund TypesHedge Fund
LEI549300GQR5ULS7W2C050
Form 3/4/5 Subject 2011 - 2026
Ardsley Partners Renewable Energy Fund LP
Ardsley Advisory Partners GP LLC
Ardsley Partners Advanced Healthcare Fund LP
Ardsley Partners I GP LLC
Marrone Bio Innovations Inc
Ardsley Advisory Partners LP
Hempleman Philip J
Ardsley Partners Fund II LP
Ardsley Ridgecrest Partners Fund LP
Ardsley Duckdive Fund LP
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Marrone Bio Innovations Inc MBII
Warrant · derivative
2021-11-11 Option exercise 618,014 $0.75 463,510
Marrone Bio Innovations Inc MBII
Common Stock
2021-11-11 Option exercise 618,014 $0.75 463,510
Marrone Bio Innovations Inc MBII
Common Stock
2021-03-12 Option exercise 741,617 $0.75 556,213
Marrone Bio Innovations Inc MBII
Warrant · derivative
2021-03-12 Option exercise 741,617 $0.75 556,213
Marrone Bio Innovations Inc MBII
Common Stock
2020-12-31 Other 50,000 $1.26 63,000
Marrone Bio Innovations Inc MBII
Common Stock
2020-12-31 Other 50,000 $1.26 63,000
Marrone Bio Innovations Inc MBII
Common Stock
2020-12-14 Option exercise 1,648,037 $0.75 1,236,028
Marrone Bio Innovations Inc MBII
Warrant · derivative
2020-12-14 Option exercise 1,648,037 $0.75 1,236,028
Marrone Bio Innovations Inc MBII
Common Stock
2020-09-15 Option exercise 343,341
Marrone Bio Innovations Inc MBII
Warrant · derivative
2020-09-15 Option exercise 343,341 $0.75 257,506
SunOpta Inc STKL
Common Stock
2020-08-18 Sell 2,300,000 $6.00 13,800,000
SunOpta Inc STKL
Common Stock
2020-08-18 Sell 1,000,000 $6.00 6,000,000
SunOpta Inc STKL
Common Stock
2020-08-06 Sell 12,500 $6.77 84,625
SunOpta Inc STKL
Common Stock
2020-08-05 Sell 50,000 $6.31 315,500
SunOpta Inc STKL
Common Stock
2020-08-05 Sell 25,000 $6.56 164,000
SunOpta Inc STKL
Common Stock
2020-08-05 Sell 25,000 $7.10 177,500
Marrone Bio Innovations Inc MBII
Common Stock
2020-05-01 Option exercise 429,176
Marrone Bio Innovations Inc MBII
Warrant · derivative
2020-05-01 Option exercise 429,176
Marrone Bio Innovations Inc MBII
Warrant · derivative
2020-04-29 Grant 741,617
Marrone Bio Innovations Inc MBII
Warrant · derivative
2020-04-29 Grant 1,648,037
showing 20 of 83 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com